113 results
Page 3 of 6
424B5
gn1qhaix
14 Mar 22
Prospectus supplement for primary offering
5:26pm
424B5
0rewwsj tdfigo80vj
10 Jan 22
Prospectus supplement for primary offering
8:00am
8-K
EX-99.1
0kx57xrf
2 Nov 21
Agile Therapeutics Reports Third Quarter 2021 Financial Results
4:11pm
8-K
EX-99.1
4w0xvztrnxh qd
8 Oct 21
Agile Therapeutics Appoints Josephine Torrente to its Board of Directors
5:23pm
424B5
h2vmd
8 Oct 21
Prospectus supplement for primary offering
5:21pm
424B5
x5owj7ehq2a6luqu
7 Oct 21
Prospectus supplement for primary offering
5:24pm
8-K
EX-99.1
2x0jyt2jtzdeq
4 Oct 21
Agile Therapeutics Announces Addition of Twirla® to a Preferred Drug Position on Medi-Cal Formulary
4:30pm
8-K
5oi5ae
10 Sep 21
Regulation FD Disclosure
4:31pm
8-K
EX-99.1
vh38ij15
10 Sep 21
Regulation FD Disclosure
4:31pm
8-K
EX-99.1
6bmgggnsj3p4wx
26 Jul 21
Agile Therapeutics Reports Second Quarter 2021 Financial Results
4:10pm
8-K
EX-99.1
awz tjhcu0ucz
4 May 21
Agile Therapeutics Reports First Quarter 2021 Financial Results
4:10pm
424B5
t9lpqag kai3j3q
18 Mar 21
Prospectus supplement for primary offering
5:01pm
8-K
EX-99.1
eqgw36lr
1 Mar 21
Results of Operations and Financial Condition
4:10pm
8-K
EX-99.1
q5tlmn
14 Jan 21
Results of Operations and Financial Condition
8:30am